{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=PF-06826647", "query": { "intervention": "PF-06826647" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 5, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-04T03:26:20.950Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03210961", "title": "A First in Human Study to Evaluate Safety, Tolerability, and Pharmacology of PF-06826647 in Healthy Subjects and Subjects With Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "PF-06826647 tablet", "type": "DRUG" }, { "name": "PF-06826647 oral suspension", "type": "DRUG" }, { "name": "Placebo oral solution/suspension", "type": "OTHER" }, { "name": "Placebo tablet", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 109, "start_date": "2017-07-14", "completion_date": "2019-01-25", "has_results": true, "last_update_posted_date": "2020-03-31", "last_synced_at": "2026-09-04T03:26:20.950Z", "location_count": 1, "location_summary": "Anaheim, California", "locations": [ { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03210961" }, { "nct_id": "NCT04134715", "title": "A Drug Drug Interaction Study Between PF-06826647 And Oral Contraceptive Steroids In Healthy Female Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "PF-06826647", "type": "DRUG" }, { "name": "Oral Contraceptive (OC)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "FEMALE", "summary": "18 Years to 60 Years · Female only" }, "enrollment_count": 15, "start_date": "2019-10-23", "completion_date": "2020-01-09", "has_results": false, "last_update_posted_date": "2020-02-05", "last_synced_at": "2026-09-04T03:26:20.950Z", "location_count": 2, "location_summary": "Coral Gables, Florida • Miami, Florida", "locations": [ { "city": "Coral Gables", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04134715" }, { "nct_id": "NCT03895372", "title": "A Study to Evaluate Safety and Efficacy of PF-06826647 For Moderate To Severe Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "PF-06826647 or Placebo", "type": "DRUG" }, { "name": "PF-06826647", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 179, "start_date": "2019-06-27", "completion_date": "2020-11-26", "has_results": true, "last_update_posted_date": "2021-08-27", "last_synced_at": "2026-09-04T03:26:20.950Z", "location_count": 24, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Anaheim, California + 13 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03895372" }, { "nct_id": "NCT04092452", "title": "A Study to Evaluate the Safety and Efficacy of PF-06650833, PF-06700841, and PF 06826647 in Adults With Hidradenitis Suppurativa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Acne Inversa" ], "interventions": [ { "name": "PF-06650833", "type": "DRUG" }, { "name": "PF-06700841", "type": "DRUG" }, { "name": "PF-06826647", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 194, "start_date": "2019-12-02", "completion_date": "2022-01-10", "has_results": true, "last_update_posted_date": "2023-06-15", "last_synced_at": "2026-09-04T03:26:20.950Z", "location_count": 63, "location_summary": "Birmingham, Alabama • Scottsdale, Arizona • Fremont, California + 42 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT04092452" }, { "nct_id": "NCT04209556", "title": "A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Ulcerative Colitis" ], "interventions": [ { "name": "PF-06826647 100 mg QD", "type": "DRUG" }, { "name": "PF-06826647 300 mg QD", "type": "DRUG" }, { "name": "PF-06826647 600 mg QD", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "PF-6826647 400 mg QD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 0, "start_date": "2020-09-30", "completion_date": "2023-10-26", "has_results": false, "last_update_posted_date": "2020-12-17", "last_synced_at": "2026-09-04T03:26:20.950Z", "location_count": 24, "location_summary": "Canoga Park, California • Inglewood, California • Newport Beach, California + 12 more", "locations": [ { "city": "Canoga Park", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "Inglewood", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04209556" } ] }